•  
  •  
 

Bulletin of Chinese Academy of Sciences (Chinese Version)

Keywords

targeting people’s health, COVID-19, interdisciplinary, science and technology innovation

Document Type

Strategy & Policy Decision Research

Abstract

Medicine and life health field is the most active and potential strategic sector in the science and technology innovation system, and is also an important guarantee to improve people’s health, promote the progress of social civilization, and maintain national security. China’s medical research system is weak in basic research, with few breakthroughs in cutting-edge innovation and high dependence on foreign medical equipment and instruments, so it is urgent to strengthen the weaknesses and make up for the shortcomings. Under the strategic guidance of “Four-pronged”, China should strengthen strategic thinking and system concepts, comprehensively plan the medium- and long-term medical science and technology development, and shape the overall capability of Chinese medical science and technology. Therefore, this study puts forward eight suggestions, such as optimizing top-level design, improving investment mechanism, solidifying basic research, promoting interdisciplinary, strengthening the transformation of achievements, promoting open collaboration, preparing for worst-case scenarios, and focusing on ethical regulations.

First page

1432

Last Page

1439

Language

Chinese

Publisher

Bulletin of Chinese Academy of Sciences

References

1 刘春鹤, 张晗, 惠文, 等. 国内外医疗数据可视化研究的现状分析与展望. 世界科技研究与发展, 2021, 43(3): 312-330. Liu C H, Zhang H, Hui W, et al. Current status analysis and prospects of domestic and foreign medical data visualization research. World Sci-Tech R&D, 2021, 43(3):312-330. (in Chinese)

2 何文斌, 冯毕龙, 王莹, 等. 常态化疫情防控下医疗机构核酸信息预警系统的设计及应用. 华西医学, 2022, 37(3): 344-348. He W B, Feng B L, Wang Y, et al. Design and application of nucleic acid information early warning system in medical institutions in coronavirus disease 2019 regular epidemic prevention and control. West China Medical Journal, 2022, 37(3): 344-348. (in Chinese)

3 樊代明, 陈鸿波, 蔡超, 等. 构建生命健康领域产学研深度融合创新体系. 科技导报, 2021, 39(16): 44-46. Fan D M, Chen H B, Cai C, et al. Constructing Industry-University-Research’s deep integration innovation system in the field of life and health. Science & Technology Review, 2021, 39(16): 44-46. (in Chinese)

4 胡志民, 贾晓峰. 创新系统理论视角下我国医学科技创新体系的框架与内涵分析. 科技管理研究, 2022, 42(3): 10-16.Hu Z M, Jia X F. Analysis of framework and contents of national medical S & T innovation system in China from the theoretical perspective of innovation system. Science and Technology Management Research, 2022, 42(3): 10-16. (in Chinese)

5 王雪, 李爱花, 李沛鑫, 等. 英国MRC和NIHR研究体系建设及对我国医学科研规划的启示. 科技管理研究, 2020, 40(7): 46-52. Wang X, Li A H, Li P X, et al. Construction of British MRC and NIHR research system and reflections on medical scientific research planning in China. Science and Technology Management Research, 2020, 40(7):46-52. (in Chinese)

6 陈宜瑜. 加强组织建设 优化资助结构 提升我国医学自主创新能力. 中国科学基金, 2009, 23(6): 321-322. Chen Y Y. Reinforcing organizational construction and optimizing the financial-support structure to promote independent innovative capacity of medicine in China. Bulletin of National Natural Science Foundation of China 2009, 23(6): 321-322. (in Chinese)

7 付磊, 尹岭, 朱曼璐, 等. 我国基础与临床医学创新体系建设研究. 中国工程科学, 2017, 19(2): 72-78.Fu L, Yin L, Zhu M L, et al. In novation system construction for China’s basic and clinical medicine. Strategic Study of CAE, 2017, 19(2): 72-78. (in Chinese)

Share

COinS